Cuffless Blood Pressure Wearables Patents: Who Leads, Where the Gaps Are 2026
Cuffless Blood Pressure Wearable Patents: Who Leads and Where the Claim Space Is Still Open
47.3% of all 1,720 records sit with just five assignees, so a freedom-to-operate check in this field starts with a very short list of companies, not a broad market scan. Annual filings rose from 106 in 2017 to a peak of 180 in 2021, then fell to 98 by 2024 — a 46% decline over that three-year span. Because 2025 and 2026 figures are still incomplete due to publication lag, this should be read as the end of a filing surge around the PTT-calibration problem, not as evidence the field is winding down.
- 1SOTERA WIRELESS INC18.7%
- 2SAMSUNG ELECTRONICS CO LTD14.6%
- 3QUALCOMM INC9.5%
- 4OMRON HEALTHCARE CO LTD2.6%
- 5MASIMO CORP2.0%
See the full cuffless blood pressure wearables analysis in Eureka
- The complete ranking, not just the top five
- Every IPC branch with its share of the corpus
- The most-cited records, and where claim space is still thin
Common questions about this landscape
How concentrated is the cuffless blood pressure patent field?
It is fairly concentrated at the top: the five leading assignees hold 814 of the 1,720 records in scope, or 47.3% of the total, and the single leading assignee alone holds 321 records. Below the top ten, which together hold 55.7% of records, the field spreads into a long tail of smaller filers with single- or double-digit counts. Anyone doing a competitive scan should expect the leader board to be short but the full ranked list, covering 100 companies, to thin out quickly after the top ten.
Is the number of new patent filings for cuffless blood pressure devices declining?
Filings peaked in 2021 at 180 and fell to 98 by 2024, a 46% decline over that span, which is the most recent year with a reasonably complete count. Counts for 2025 and 2026 look lower still, but that is expected: publication typically lags filing by around 18 months, so the most recent years are always undercounted at the point of measurement. The honest read is a cooling filing pace after a 2021 surge, not a field in retreat.
What patent classes cover cuffless blood pressure wearable technology?
Almost all records, 96.6% of the 1,720 in scope, carry an A61B classification covering diagnosis and surgery apparatus, reflecting that nearly every filing touches the physical sensor or measurement hardware. Healthcare informatics (G16H) appears in 7.0% of records, general digital data processing (G06F) in 3.8%, and AI-based computing (G06N) in just 1.9%. Because a single record can carry several IPC classes, these shares add up to more than 100% and should not be summed or treated as mutually exclusive categories.
Disclaimer. This analysis is based on Patsnap Eureka data drawn from a limited snapshot of global patent records and is provided for general information and reference only. Patent data carries inherent limitations — recent filings are under-counted because of publication lag, counts may be on a record or family basis, classification and applicant-name data may contain errors or duplicates, and the underlying search query defines the scope shown — so the analysis may be incomplete or inaccurate and may not reflect the full technology landscape.
Nothing here is an exhaustive prior-art, novelty, freedom-to-operate or validity search, nor does it constitute legal, financial or professional advice, and it should not be relied upon as such. Verify independently and review with qualified patent and legal professionals before acting on it.
Method: Filing trend and technology composition. Derived from a Patsnap search on Cuffless Blood Pressure Wearables covering 2015–2026, data cut-off 2026-07-31. Counts reflect published records only and shift as new filings publish. Every share divides by all records in scope. Data: Patsnap Eureka. See the full landscape report.